Browse the detailed record of transactions filed by Marianne Catharina Svanborg, Président du Conseil. Officer active across 2 companies, notably Hamlet BioPharma AB. Cumulatively, 1 reports have been logged. History available since 26 March 2026. The latest transaction was disclosed on 26 March 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Marianne Catharina Svanborg is the chairman of the board at Hamlet BioPharma AB. In this role, she oversees the board's activities and ensures that the company meets its strategic objectives. Marianne brings extensive experience in corporate governance.